What stage does BioScience Ventures Group AG invest at?

BioScience Ventures Group AG invests at the Pre-Seed, Seed, Series A stages.

What is BioScience Ventures Group AG's typical check size?

BioScience Ventures Group AG typically writes checks of $220K – $550K.

What sectors does BioScience Ventures Group AG focus on?

BioScience Ventures Group AG focuses on Biotech, Healthtech, Medical Devices.

Where is BioScience Ventures Group AG located?

BioScience Ventures Group AG is headquartered in Munich, DE.

BioScience Ventures Group AG

Angel network

Munich · Pre-Seed–Series A · 2 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

✨ Fox Verdict

Investment thesis

BSVG is a network of business angels focused solely on early-stage life-science investments, writing rounds of roughly EUR 0.2 to 0.5 million each. Beyond capital, the group brings a team with medical and pharmacological backgrounds specialized in drug development and the design of preclinical and clinical studies, particularly in the field of biologics such as antibodies and proteins. This domain expertise, combined with long experience in the investment business, is used to improve the efficiency of investments and reduce development costs for portfolio companies.

Invests inBiotech Healthtech Medical DevicesAustriaGermanyMunichSwitzerland

Source: firm website, verified Aug 3, 2026.

Stage

Pre-Seed–Series A

Check

$220K – $550K

Munich, DE

Instruments

Equity

Founded

2001

Tracked investments

Team · 2 people

from the firm's website & public directories

Nicole Wistuba· Managing Director

Managing Director of BSVG who joined in 2001 after completing a PhD in biology at the University of Würzburg. She oversees the company's operational business and sits on the boards of ugichem GmbH, MagnaMedics GmbH and APEPTICO.

n•••@bsvg.comreveal

Markus Heiss· Prof. Dr.

A surgeon specializing in visceral and vascular surgery, he serves as Medical Director of the Department of Visceral, Vascular and Transplant Surgery at Medical Center Cologne-Merheim and holds a surgery faculty chair at the University of Witten/Herdecke. His specialties include surgical oncology, tumor immunology, minimally invasive surgery and transplant surgery.

Investments · 3 tracked

founders shown can be your intro path

APEPTICOapeptico.com

PartnerNicole Wistuba· solo GP

MagnaMedicsmagnamedics.com

PartnerNicole Wistuba· solo GP

Nano4Imagingnano4imaging.com

Develops and produces contrast agents and devices for in-vivo MRI imaging of implants, transplants and minimally invasive devices such as catheters and guidewires.

PartnerNicole Wistuba· solo GP

Frequently asked questions

What stage does BioScience Ventures Group AG invest at?: BioScience Ventures Group AG invests at the Pre-Seed, Seed, Series A stages.
What is BioScience Ventures Group AG's typical check size?: BioScience Ventures Group AG typically writes checks of $220K – $550K.
What sectors does BioScience Ventures Group AG focus on?: BioScience Ventures Group AG focuses on Biotech, Healthtech, Medical Devices.
Where is BioScience Ventures Group AG located?: BioScience Ventures Group AG is headquartered in Munich, DE.

Similar investors

Draper Associates

Draper Associates is a venture capital firm that invests in technology startups across AI, robotics, blockchain, healthcare, aerospace, and frontier deep-tech fields.

$500K – $5M

Foresite Capital

Foresite Capital is a multi-stage investment firm focused on healthcare and life sciences, backing companies across all stages of growth. It applies a data science-driven approach to invest in businesses leveraging biology and big data to transform healthcare.

Forbion

Forbion is a global venture capital firm focused on advancing biotech innovations and sustainable solutions aimed at improving human and planetary health.

Pontifax Venture Capital

Pontifax is an investment firm focused on life sciences and healthcare technologies, backing companies across all development stages from early research to clinical-stage growth.